Dr. Elisa K. Boden, MD

Dr. Boden practices at OHSU Hospital in Portland, Oregon, part of State of Oregon.

Dr. Boden's NPI, 1932167400, was assigned on May 3, 2006. Dr. Boden graduated from Pritzker School of Medicine in 2003. Dr. Boden's Oregon license number on file is MD201931.

Dr. Boden's primary practice is OHSU Hospital, at 3181 SW Sam Jackson Park Road, Portland, OR 97239 in Multnomah County. The practice phone is (503) 494-9000.

Dr. Boden's primary practice is OHSU Hospital in Portland, Oregon, part of State of Oregon. Dr. Boden is also affiliated with Hillsboro Medical Center. The medical group on file is Oregon Health & Science University (OHSU). Dmand AI also links Dr. Boden to 1 more clinical lab, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Boden practices, 3 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Boden's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Boden is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Boden's licenses on file in 4 states: Oregon, Washington, Massachusetts and New York.

Dmand AI lists acid reflux, chronic inflammatory bowel disease (IBD), colonoscopy, gastroenteritis, intestinal or bowel obstruction and upper GI endoscopy among the conditions Dr. Boden treats.

CMS data shows 234 Medicare services from Dr. Boden across 8 procedure codes in 2024, for 133 Medicare patients. Medicare paid $17,449 for them.

CMS counts 133 Medicare patients who saw Dr. Boden in 2024. The largest group is 65 to 74, with 60 patients. 59% of them have high blood pressure, and 50% have high cholesterol. 31% are also on Medicaid. Their average risk score is 1.87, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Boden's median patient age at 54, with 58% women.

In 2024, Dr. Boden wrote 432 Medicare Part D claims for 121 patients. 53% of them were for generic drugs. CMS names the drug for 280 of them, across 11 drugs with 11 or more claims each, at $1,992,550 in total drug cost. In 2023, CMS named 343 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Boden for performance year 2024, reported through an alternative payment model (APM). Dr. Boden accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Boden as offering telehealth. CMS counts 59 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Boden, more than 66% of the clinicians it reports for that procedure.

Dmand AI links 13 papers to Dr. Boden, published from 2012 to 2025. 2020 was the busiest year, with 2. The most frequent topics are CD4-Positive T-Lymphocytes, Antigens, CD and Colitis, Ulcerative. Dr. Boden has published most often in Clin Gastroenterol Hepatol. Dr. Boden's most frequent co-authors are James Daniel Lord, MD, Michael V. Chiorean, MD and Michael Gluck, MD.

CMS Open Payments shows 12 general payments to Dr. Boden from 5 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $275.

Dmand AI lists 1 award for Dr. Boden, most recently CMS Stage 1 EHR in 2013.

Dr. Boden graduated from Pritzker School of Medicine in 2003.

Dr. Boden is in network with 18 carriers, including Elevance, Aetna and United Healthcare. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.